C WorldWide Group Holding A S Has $13.91 Million Position in Waters Co. (NYSE:WAT)

C WorldWide Group Holding A S lowered its position in Waters Co. (NYSE:WATFree Report) by 75.8% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 37,496 shares of the medical instruments supplier’s stock after selling 117,280 shares during the quarter. C WorldWide Group Holding A S’s holdings in Waters were worth $13,910,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Principal Financial Group Inc. increased its position in Waters by 70.7% during the 3rd quarter. Principal Financial Group Inc. now owns 656,019 shares of the medical instruments supplier’s stock valued at $236,095,000 after purchasing an additional 271,804 shares during the period. Robeco Institutional Asset Management B.V. increased its position in Waters by 34.4% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 393,890 shares of the medical instruments supplier’s stock valued at $141,757,000 after purchasing an additional 100,811 shares during the period. JPMorgan Chase & Co. increased its position in Waters by 37.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 305,661 shares of the medical instruments supplier’s stock valued at $110,005,000 after purchasing an additional 82,865 shares during the period. Applied Finance Capital Management LLC increased its position in Waters by 3,627.0% during the 3rd quarter. Applied Finance Capital Management LLC now owns 68,987 shares of the medical instruments supplier’s stock valued at $24,828,000 after purchasing an additional 67,136 shares during the period. Finally, Smith Group Asset Management LLC acquired a new stake in Waters during the 4th quarter valued at approximately $22,188,000. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Trading Down 1.7 %

NYSE WAT opened at $374.24 on Monday. The stock has a market capitalization of $22.22 billion, a price-to-earnings ratio of 34.94, a PEG ratio of 3.79 and a beta of 1.01. Waters Co. has a one year low of $279.24 and a one year high of $423.56. The company has a debt-to-equity ratio of 1.14, a current ratio of 0.94 and a quick ratio of 0.65. The business’s fifty day moving average is $388.85 and its 200-day moving average is $366.15.

Waters (NYSE:WATGet Free Report) last announced its quarterly earnings data on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. Equities research analysts predict that Waters Co. will post 12.86 EPS for the current year.

Wall Street Analysts Forecast Growth

WAT has been the subject of a number of recent analyst reports. UBS Group increased their target price on shares of Waters from $405.00 to $410.00 and gave the company a “neutral” rating in a research report on Thursday, February 13th. Stifel Nicolaus increased their price target on Waters from $332.00 to $360.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Sanford C. Bernstein upgraded shares of Waters from a “market perform” rating to an “outperform” rating and set a $430.00 price objective for the company in a research note on Friday, January 10th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Waters from $310.00 to $325.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Finally, Barclays upgraded shares of Waters from an “underweight” rating to an “equal weight” rating and lifted their price objective for the company from $360.00 to $415.00 in a research note on Monday, February 10th. Ten investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $390.40.

View Our Latest Stock Analysis on WAT

Waters Company Profile

(Free Report)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Recommended Stories

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WATFree Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.